As of 2025-05-15, the Relative Valuation of Champions Oncology Inc (CSBR) is 8.36 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.47 USD, the upside of Champions Oncology Inc based on Relative Valuation is 29.3%.
The range of the Relative Valuation is 7.02 - 14.21 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 30.6x | 20.1x |
| Forward P/E multiples | 15.1x - 18.1x | 15.9x |
| Fair Price | 7.02 - 14.21 | 8.36 |
| Upside | 8.5% - 119.6% | 29.3% |
| Date | P/E |
| 2025-04-03 | 17.58 |
| 2025-04-02 | 19.04 |
| 2025-04-01 | 18.53 |
| 2025-03-31 | 18.68 |
| 2025-03-28 | 19.60 |
| 2025-03-27 | 20.44 |
| 2025-03-26 | 20.59 |
| 2025-03-25 | 19.99 |
| 2025-03-24 | 21.09 |
| 2025-03-21 | 20.61 |
| 2025-03-20 | 21.82 |
| 2025-03-19 | 21.84 |
| 2025-03-18 | 20.68 |
| 2025-03-17 | 21.84 |
| 2025-03-14 | 19.86 |
| 2025-03-13 | 19.13 |
| 2025-03-12 | 20.55 |
| 2025-03-11 | 21.07 |
| 2025-03-10 | 19.15 |
| 2025-03-07 | 21.39 |
| 2025-03-06 | 21.54 |
| 2025-03-05 | 22.38 |
| 2025-03-04 | 22.23 |
| 2025-03-03 | 22.36 |
| 2025-02-28 | 22.12 |
| 2025-02-27 | 21.99 |
| 2025-02-26 | 22.08 |
| 2025-02-25 | 20.61 |
| 2025-02-24 | 20.12 |
| 2025-02-21 | 21.88 |
| 2025-02-20 | 22.57 |
| 2025-02-19 | 23.24 |
| 2025-02-18 | 23.24 |
| 2025-02-14 | 23.82 |
| 2025-02-13 | 23.80 |
| 2025-02-12 | 23.65 |
| 2025-02-11 | 22.98 |
| 2025-02-10 | 24.51 |
| 2025-02-07 | 23.67 |
| 2025-02-06 | 22.94 |
| 2025-02-05 | 23.71 |
| 2025-02-04 | 23.11 |
| 2025-02-03 | 21.54 |
| 2025-01-31 | 23.65 |
| 2025-01-30 | 23.02 |
| 2025-01-29 | 23.86 |
| 2025-01-28 | 23.09 |
| 2025-01-27 | 25.18 |
| 2025-01-24 | 24.96 |
| 2025-01-23 | 24.45 |